Australia TGA ARTG recordE-tegra Stent Graft System – Contralateral Leg - Abdominal aortic aneurysm stent
Australia TGA ARTG Registered Device · Cryolife Medical (Australia) Company Pty Ltd · Jotec GmbH · Class III · Started May 12, 2022
Good Name: Cryolife Medical (Australia) Company Pty Ltd - E-tegra Stent Graft System – Contralateral Leg - Abdominal aortic aneurysm stent
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- May 12, 2022
- Effective Date
- May 12, 2022
- Name
- Jotec GmbH
- Country
- Germany
- Address
- Lotzenacker 23, Hechingen, 72379
The E-tegra Stent Graft System is indicated for the endovascular treatment of infrarenal aortic aneurysms. These aneurysms can also affect the common iliac artery.
Access comprehensive regulatory information for E-tegra Stent Graft System – Contralateral Leg - Abdominal aortic aneurysm stent in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Cryolife Medical (Australia) Company Pty Ltd, manufactured by Jotec GmbH in Germany. The device registration started on May 12, 2022.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.